Infosys shares gain over 1% after acquiring two US-based companies for $560 million. Here's what Nomura, Emkay are saying

Shares of IT services major Infosys gained as much as 1% to their day's high of Rs 1,293 on the BSE on Friday after announcing that it will acquire two U.S.-based firms in all-cash deals: healthcare digital transformation company Optimum Healthcare IT for $465 million and insurance technology consulting firm Stratus for $95 million. The gains came even as Dalal Street witnessed a sharp selloff, with benchmark indices Nifty and Sensex plunging over 1% each.

The combined deal value of $560 million makes it the second-largest acquisition since 2025, behind Tata Consultancy Services’ $700 million purchase of Coastal Cloud in December last year.

Infosys said the larger acquisition, Optimum, will strengthen its presence in the healthcare provider segment by adding new client relationships, expanding its technology capabilities and creating synergies across new buying centres.


Optimum, previously owned by private equity firm Achieve Partners, along with its founders and management, will bring over 1,600 employees with deep healthcare expertise into Infosys.

Chief executive Salil Parekh said the integration of Optimum’s provider capabilities with Infosys Topaz and Infosys Cobalt will help deliver end-to-end cloud, data and digital transformation for healthcare clients at scale.

Gene Scheurer, CEO and co-founder of Optimum Healthcare IT, said the backing of Infosys’ global scale and long-term investments will support faster AI-led and digital growth, while maintaining the company’s existing service focus and client relationships.

Also Read | Less than half equity mutual funds offer positive returns in FY26. Were they a part of your portfolio?

The second acquisition, Stratus, was earlier owned by U.S.-based Smart Global Holdings, along with its founders and management. It adds a team of more than 450 professionals to Infosys.

Infosys said combining Stratus’ expertise in Guidewire and property and casualty insurance platforms with its AI offerings will help improve customer experience for insurers and support core modernisation, cloud adoption and data-driven transformation. The deal is also expected to widen Infosys’ reach among global insurance clients and decision-makers.

What are experts saying?

Nomura has maintained its Buy rating on Infosys with a target price of Rs 1,810. The brokerage noted that the two recent acquisitions, along with Versent which is awaiting regulatory approvals, could add around 225 basis points to Infosys’ revenue growth in FY27F, assuming a full 12-month contribution. It believes the deals will help the company tap into new client segments while strengthening its capabilities in the life sciences and healthcare verticals, particularly through the Optimum acquisition.

Emkay Global has also reiterated a Buy call on Infosys with a target price of Rs 1,450. The brokerage said the acquisitions enhance Infosys’ vertical-focused consulting and digital transformation offerings across provider-side healthcare IT and property and casualty insurance platforms. It added that the integration of AI platform Topaz and cloud platform Cobalt into domain-specific workflows will deepen further. The deals will bring in around 2,000 professionals, including about 1,600 from Optimum and 450 from Stratus, while expanding Infosys’ presence in high-value client segments and strengthening its position in complex, regulated industries.

Sensex, Nifty today: Catch the LIVE stock market action here

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times.)